期刊文献+

HB-EGF与坏死性小肠结肠炎的研究进展 被引量:3

Heparin-binding epidermal growth factor-like growth factor and necrotizing enterocolitis
原文传递
导出
摘要 坏死性小肠结肠炎(necrotizing enterocolitis,NEC)是一种常见且严重的胃肠道疾病,主要发生在早产儿.尽管采取了诸多措施,NEC的病死率仍然很高.近年来,诸多研究显示肝素结合表皮生长因子样生长因子(heparin-binding epidermal growth factor-like growth factor,HB-EGF)可以保护肠道上皮细胞免受多种伤害.并且,在成年大鼠肠道缺血再灌注损伤模型和新生NEC模型鼠进行的实验显示,HB-EGF可以保护肠道免受损伤.这些研究为NEC的治疗和预防提供了一个新的研究方向. Necrotizing enterocolitis(NEC) is a common and devastating gastrointestinal disease that occurs predominantly in premature infants.Despite various advances in management,the mortality of this disease remains high.During the last decade,studies have shown that heparin-binding epidermal growth factor-like growth factor (HB-EGF),can protect intestinal epithelial cells from various forms of injury in vitro.Furthermore,studies using both an intestinal ischemia-reperfusion injury model in adult rats and neonatal rat model of NEC,have shown that HB-EGF can protect the intestines from injury.Present studies provide a new research direction in the prevention and treatment.
出处 《国际儿科学杂志》 2013年第6期585-588,共4页 International Journal of Pediatrics
关键词 HB-EGF 坏死性小肠结肠炎 肠道 损伤 HB-EGF Necrotizing enterocolitis Intestine Injury
  • 相关文献

参考文献32

  • 1Thompson AM,Bizzarro MJ. Necrotizing enterocolitis in newborns:pathogenesis,prevention and management[J].Drugs,2008,(09):1227-1238.doi:10.2165/00003495-200868090-00004.
  • 2Zhang Y,Ortega G,Camp M. Necrotizing enterocolitis requiting surgery:outcomes by intestinal location of disease in 4371 infants[J].Journal of Pediatric Surgery,2011,(08):1475-1481.
  • 3Clark RH,Gordon P,Walker WM. Characteristics of patients who die of necrotizing enterocolitis[J].Journal of Perinatology,2012,(03):199-204.
  • 4Frost BL,Caplan MS. Probiotics and prevention of neonatal necrotizing enterocolitis[J].Current Opinion in Pediatrics,2011,(02):151-155.
  • 5Radulescu A,Yu X,Orvets ND. Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis[J].Journal of Pediatric Surgery,2010,(04):729-734.
  • 6Feng J,E1-Assal ON,Besner GE. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats[J].Journal of Pediatric Surgery,2006,(01):144-149.
  • 7Feng J,El-Assal ON,Besner GE. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis[J].Journal of Pediatric Surgery,2006,(04):742-747.
  • 8Martin AE,Luquette MH,Besner GE. Timing,route,and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury[J].Journal of Pediatric Surgery,2005,(11):1741-1747.
  • 9E1-Assal ON,Radulescu A,Besner GE. Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation[J].Surgery,2007,(02):234-242.doi:10.1016/j.surg.2007.04.003.
  • 10Radulescu A,Zorko NA,Yu X. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis[J].Pediatric Research,2009,(04):437-442.doi:10.1203/PDR.0b013e3181994fa0.

同被引文献24

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部